Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Partners4Access

- PMLiVE

UK Bribery Act: A game changer

The Director of the Serious Fraud Office intends to enforce the Act ‘vigorously’ – it would be wise to take him at his word

UK flag

MRC funds UK research using 22 AstraZeneca compounds

Provides £7m for projects covering Alzheimer’s, cancer, lung disease and rare conditions

- PMLiVE

UK considers greater self-regulation of pharmacies

And MHRA to review sanctions and penalties

Market access opportunities in China

Pope Woodhead highlights the key steps to accessing the high-value therapeutics market in China

Novartis building

NICE backs Novartis’ Tobi Podhaler in cystic fibrosis

But draft guidance doesn't recommend Forest’s Colobreathe

UK flag

UK could allow patented drugs to be used in clinical trials

Government proposes update to Patents Act to restrict when companies can sue for infringement

- PMLiVE

Ireland forges drug pricing pact with pharma

Could cut drug bill by €400m

UK flag

UK doctors to face annual appraisals

Will need to show they are aware of new advances in medicine

- PMLiVE

NICE and ABPI clash over access to medicines

Trade body says research shows medicines underused but NICE claims new figures 'higher than expected'

Open Health adds pH Associates to its roster

UK real world data specialist will bolster Open's market access offering

Pharma must ’embrace the new reality’ and meet payers’ needs

This means capturing better health economic data during product development, says Takeda's Trevor Smith

- PMLiVE

Patient access schemes likely to remain under VBP, says NICE

New and existing schemes expected to have place within UK’s new pricing environment

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links